Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

Patients receive adalimumab 80 mg followed by 40 mg at week 1 and 40 mg every other week (EOW) thereafter.

Patients will receive 2 injections of placebo at week 0, one injection at week 1 and one injection every other week (EOW) thereafter.